Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Insolvency Petition

Cian Healthcare Insolvency Petition

Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.

Source

BSE filing, BSE: 542678. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cian Healthcare Ltd: key numbers

Share price
₹32.20
Market cap
₹80.50 Cr
Revenue (annual)
₹28.30 Cr
Net profit (annual)
₹-23.29 Cr
Promoter holding
95.00%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cian Healthcare Ltd

All →

Other insolvency petition announcements

All →